Clinical Trial Update: Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing azacitidine plus pevonedistat versus azacitidine in adults with acute myeloid leukemia not eligible for standard chemotherapy; status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• azacitidine + pevonedistat

Snippet

Sponsor: PETHEMA Foundation | Conditions: Leukemia, Myeloid, Acute | Phase 3 | Status: ACTIVE_NOT_RECRUITING